Evaluation of FreeStyle Libre in pediatric t1dm: improved glycemic control, reduction in diabetic ketoacidosis and severe hypoglycemia
https://doi.org/10.14341/probl12877
Abstract
BACKGROUND: Self-monitoring of blood glucose (SMBG) with glucometers provides only a snapshot of the glycemic profile and is accompanied by significant psychological discomfort and pain, especially in children. Flash Glucose Monitoring System — FreeStyle Libre (FSL) overcomes many of the barriers associated with glucose measurement and improves metabolic control.
AIM: To evaluate the efficacy of FSL in children with type 1 diabetes mellitus (T1DM) in terms of glycemic control, episodes of severe hypoglycemia (SH) and diabetic ketoacidosis (DKA).
MATERIALS AND METHODS. A multicenter, prospective, observational study in real clinical practice was carried out. A total of 469 subjects (258 boys and 211 girls) aged 4–18 were included in the study. The median age was 11.3 (8.4–14.6) years, duration of T1DM — 4.2 (2.1–7.1) years. After FSL start, patient was followed up for 6 months.
RESULTS: After 3 and 6 months of FSL use, HbA1c significantly decreased from 7.4% to 7.1% and 7.2%, respectively (p<0.001). The number of children with HbA1c ><7.5% increased from 51% to 60% and 58% at 3 and 6 months, respectively (p><0.001). The incidence of DKA and SH, as well as the proportion of patients experiencing at least one episode of DKA and SH, were significantly reduced after 6 months of FSL use compared with baseline (p><0.001).
CONCLUSION: The Study demonstrated a significant improvement in metabolic control in children with T1DM 6 months after FSL start: decrease in HbA1c, accompanied by reduction in incidence of DKA and SH.
About the Authors
D. N. LaptevRussian Federation
Dmitry N. Laptev, PhD
Moscow
Competing Interests:
Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
O. B. Bezlepkina
Russian Federation
Olga B. Bezlepkina, PhD
Moscow
Competing Interests:
Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
E. S. Demina
Russian Federation
Elena S. Demina, PhD
Moscow
Competing Interests:
Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
O. A. Malievskiy
Russian Federation
Oleg A. Malievskiy, PhD, professor
Ufa
Competing Interests:
Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
I. L. Nikitina
Russian Federation
Irina L. Nikitina, professor, PhD
St. Petersburg
Competing Interests:
Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
I. G. Samoilova
Russian Federation
Iuliia G. Samoilova, PhD, professor
Tomsk
Competing Interests:
Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
V. A. Peterkova
Russian Federation
Valentina A. Peterkova, PhD, professor, academician of RAS
Moscow
Competing Interests:
Автор декларирует отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
References
1. Dedov II, Shestakova MV, Mayorov AYu, et al. Standards of specialized diabetes care. Diabetes Mellitus. 2019;22(S1):1-144 (In Russ.). doi: https://doi.org/10.14341/DM221S1.
2. Peterkova VA, Shestakova MV, Bezlepkina OB, et al. Diabetes mellitus type 1 in childhood. Diabetes mellitus. 2020;23(1S):4-40. (In Russ.). doi: https://doi.org/10.14341/DM12504.
3. Dedov II, Shestakova MV, Mayorov AY, et al. Diabetes mellitus type 1 in adults. Diabetes mellitus. 2020;23(1S):42-114. (In Russ.) doi: https://doi.org/10.14341/DM12505.
4. DiMeglio LA, Acerini CL, Codner E, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes. 2018;19:105-114. doi: https://doi.org/10.1111/pedi.12737
5. Campbell FM, Murphy NP, Stewart C, et al. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study. Pediatr Diabetes. 2018;19(7):1294-1301. doi: https://doi.org/10.1111/pedi.12735
6. Tauschmann M, Hermann JM, Freiberg C, et al. Reduction in Diabetic Ketoacidosis and Severe Hypoglycemia in Pediatric Type 1 Diabetes During the First Year of Continuous Glucose Monitoring: A Multicenter Analysis of 3,553 Subjects From the DPV Registry. Diabetes Care. 2020;43(3):e40-e42. doi: https://doi.org/10.2337/dc19-1358
7. Leiva-Gea I, García Vázquez J, Liñán Jurado FR, et al. Introduction of flash glucose monitoring in children with Type 1 diabetes: experience of a single-centre in Spain. ESPE Abstracts. 2019;92:LB-20.
8. Suzuki J, Urakami T, Yoshida K, et al. Association between scanning frequency of flash glucose monitoring and continuous glucose monitoring‐derived glycemic makers in children and adolescents with type 1 diabetes. Pediatr Int. 2021;63(2):154-159. doi: https://doi.org/10.1111/ped.14412
9. Messaaoui A, Tenoutasse S, Crenier L. Flash Glucose Monitoring Accepted in Daily Life of Children and Adolescents with Type 1 Diabetes and Reduction of Severe Hypoglycemia in Real-Life Use. Diabetes Technol Ther. 2019;21(6):329-335. doi: https://doi.org/10.1089/dia.2018.0339
10. Deeb A, Yousef H, Al Qahtani N, et al. Novel ambulatory glucosesensing technology improves hypoglycemia detection and patient monitoring adherence in children and adolescents with type 1 diabetes. J Diabetes Metab Disord. 2019;18(1):1-6. doi: https://doi.org/10.1007/s40200-018-0351-9
11. Al Hayek AA, Robert AA, Al Dawish MA. Evaluation of FreeStyle Libre Flash Glucose Monitoring System on Glycemic Control, HealthRelated Quality of Life, and Fear of Hypoglycemia in Patients with Type 1 Diabetes. Clin Med Insights Endocrinol Diabetes. 2017;10. doi: https://doi.org/10.1177/1179551417746957
12. Vergier J, Samper M, Dalla-Vale F, et al. Evaluation of flash glucose monitoring after long-term use: A pediatric survey. Prim Care Diabetes. 2019;13(1):63-70. doi: https://doi.org/10.1016/j.pcd.2018.08.004
Supplementary files
|
1. Рисунок 1. Показатели времени в диапазонах в зависимости от частоты сканирования датчика за сутки. ВЦД — время в целевом диапазоне 3,9–10 ммоль/л, ВВД — время выше целевого диапазона >10 ммоль/л, ВНД — время ниже целевого диапазона <3,9 ммоль/л. Данные представлены в виде: медиана (интерквартильный диапазон) и отдельные значения. Использован критерий Краскела–Уоллиса. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(512KB)
|
Indexing metadata ▾ |
|
2. Рисунок 2. Уровень HbA1c в зависимости от частоты сканирования датчика за сутки. Данные представлены в виде: медиана (интерквартильный диапазон) и отдельные значения. Использован критерий Краскела–Уоллиса. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(208KB)
|
Indexing metadata ▾ |
Review
For citations:
Laptev D.N., Bezlepkina O.B., Demina E.S., Malievskiy O.A., Nikitina I.L., Samoilova I.G., Peterkova V.A. Evaluation of FreeStyle Libre in pediatric t1dm: improved glycemic control, reduction in diabetic ketoacidosis and severe hypoglycemia. Problems of Endocrinology. 2022;68(3):86-92. (In Russ.) https://doi.org/10.14341/probl12877

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).